Yan Ji

4.3k total citations · 1 hit paper
114 papers, 2.9k citations indexed

About

Yan Ji is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yan Ji has authored 114 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 39 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yan Ji's work include Advanced Breast Cancer Therapies (21 papers), Cancer-related Molecular Pathways (11 papers) and HER2/EGFR in Cancer Research (10 papers). Yan Ji is often cited by papers focused on Advanced Breast Cancer Therapies (21 papers), Cancer-related Molecular Pathways (11 papers) and HER2/EGFR in Cancer Research (10 papers). Yan Ji collaborates with scholars based in United States, China and Switzerland. Yan Ji's co-authors include Marilyn E. Morris, George P. Studzinski, Nanjoo Suh, Hong Jin Lee, Wei Yan, Handong Wang, Yuhsin Kuo, Gang Chen, Shiby Paul and Bandaru S. Reddy and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yan Ji

108 papers receiving 2.8k citations

Hit Papers

Ribociclib plus fulvestrant for postmenopausal women with... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
    2021 161 citations Yan Ji et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Ji United States 32 1.3k 704 383 378 373 114 2.9k
Yueshui Zhao China 33 1.5k 1.1× 715 1.0× 328 0.9× 618 1.6× 502 1.3× 116 3.3k
Yu‐Jia Chang Taiwan 35 2.2k 1.6× 764 1.1× 494 1.3× 590 1.6× 359 1.0× 153 4.0k
Ming Gao China 33 1.6k 1.2× 585 0.8× 360 0.9× 623 1.6× 255 0.7× 214 3.5k
Patrick M. Navolanic United States 19 2.3k 1.7× 1.0k 1.4× 371 1.0× 562 1.5× 324 0.9× 23 3.5k
Nicoletta Ferrari Italy 36 2.0k 1.5× 785 1.1× 366 1.0× 737 1.9× 611 1.6× 113 3.7k
Ziming Dong China 34 2.1k 1.6× 712 1.0× 172 0.4× 692 1.8× 413 1.1× 127 3.3k
Yasuyoshi Miyata Japan 33 1.5k 1.2× 641 0.9× 570 1.5× 608 1.6× 256 0.7× 174 3.3k
Shin Kim South Korea 29 1.4k 1.1× 499 0.7× 181 0.5× 323 0.9× 442 1.2× 142 2.6k
Junji Magae Japan 33 1.9k 1.5× 841 1.2× 318 0.8× 690 1.8× 380 1.0× 136 3.7k

Countries citing papers authored by Yan Ji

Since Specialization
Citations

This map shows the geographic impact of Yan Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ji more than expected).

Fields of papers citing papers by Yan Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ji. The network helps show where Yan Ji may publish in the future.

Co-authorship network of co-authors of Yan Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Ji. A scholar is included among the top collaborators of Yan Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Ji. Yan Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cardoso, Fátima, William Jacot, Sherko Küemmel, et al.. (2025). 600- vs 400-mg First-Line Ribociclib in Hormone Receptor–Positive/ ERBB2 -Negative Advanced Breast Cancer. JAMA Oncology. 11(11). 1356–1356.
2.
3.
Ramirez‐Perez, Francisco I., Zhe Sun, Shumpei Fujie, et al.. (2024). PAI-1 Regulates the Cytoskeleton and Intrinsic Stiffness of Vascular Smooth Muscle Cells. Arteriosclerosis Thrombosis and Vascular Biology. 44(10). 2191–2203. 6 indexed citations
4.
Ji, Yan, Hilmar Schiller, Michelle Quinlan, et al.. (2024). Use of Pharmacokinetic and Pharmacodynamic Data to Develop the CDK4/6 Inhibitor Ribociclib for Patients with Advanced Breast Cancer. Clinical Pharmacokinetics. 63(2). 155–170. 2 indexed citations
5.
6.
Staubach, Petra, Montserrat Álvaro‐Lozano, Bülent Enis Şekerel, et al.. (2023). Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis. Pediatric Allergy and Immunology. 34(7). e13982–e13982. 12 indexed citations
7.
8.
Ji, Yan, Deborah Knee, Lore Gruenbaum, et al.. (2023). Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment. CPT Pharmacometrics & Systems Pharmacology. 12(3). 413–424. 8 indexed citations
9.
Jin, Minliang, Haijun Liu, Xiangguo Liu, et al.. (2023). Complex genetic architecture underlying the plasticity of maize agronomic traits. Plant Communications. 4(3). 100473–100473. 18 indexed citations
10.
Rocque, Gabrielle B., Joanne L. Blum, Yan Ji, et al.. (2022). 266P Real-world quality of life (QoL) in patients with HR+/HER2-advanced breast cancer (ABC) treated with palbociclib: Final clinical outcome assessment (COA) analysis from POLARIS. Annals of Oncology. 33. S659–S659. 2 indexed citations
11.
Ji, Yan, et al.. (2020). Evaluation of Absolute Oral Bioavailability and Bioequivalence of Ribociclib, a Cyclin‐Dependent Kinase 4/6 Inhibitor, in Healthy Subjects. Clinical Pharmacology in Drug Development. 9(7). 855–866. 16 indexed citations
12.
Benschop, Robert J., Chi-Kin Chow, Yu Tian, et al.. (2019). Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. mAbs. 11(6). 1175–1190. 34 indexed citations
13.
Xiong, Qiyan, Jia Wang, Yan Ji, et al.. (2016). The functions of the variable lipoprotein family of Mycoplasma hyorhinis in adherence to host cells. Zhongguo yufang shouyi xuebao. 40(11). 1049–1054. 4 indexed citations
14.
Ma, Tao, et al.. (2013). Pesticide-Induced Gene Mutations and Parkinson Disease Risk: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 17(11). 826–832. 17 indexed citations
15.
Liu, Xiao, Liming Hao, Yan Ji, et al.. (2010). Genetic repression of mouse VEGF expression regulates coagulation cascade. IUBMB Life. 62(11). 819–824. 17 indexed citations
16.
Ji, Yan, et al.. (2009). ABC transporters and isothiocyanates: potential for pharmacokinetic diet–drug interactions. Biopharmaceutics & Drug Disposition. 30(7). 335–344. 28 indexed citations
17.
Lee, Hong Jin, Hao Liu, Catherine Goodman, et al.. (2006). Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. Biochemical Pharmacology. 72(3). 332–343. 55 indexed citations
18.
Ji, Yan. (2001). Pharmacokinetic study of bicyclol in thirty health volunteers. Zhongguo linchuang yaolixue yu zhiliaoxue. 4 indexed citations
19.
Zhou, Yonghong, Junliang Yang, Yan Ji, & Youliang Zheng. (1999). Biosystematic studies on Hystrix longearistata from Japan and Hystrix duthiei from China (Poaceae: Triticeae). Journal of Systematics and Evolution. 37(4). 386–393. 8 indexed citations
20.
Zhou, Yonghong, et al.. (1997). A revision of Roegneria mayebarana(Honda) Ohwi from China. 17(1). 19–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueshui Zhao Breakdown of academic impact, for papers by Yu‐Jia Chang Breakdown of academic impact, for papers by Ming Gao Breakdown of academic impact, for papers by Patrick M. Navolanic Breakdown of academic impact, for papers by Nicoletta Ferrari Breakdown of academic impact, for papers by Ziming Dong Breakdown of academic impact, for papers by Yasuyoshi Miyata Breakdown of academic impact, for papers by Shin Kim Breakdown of academic impact, for papers by Junji Magae
Rankless by CCL
2026